Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Loh

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Drug Discovery Today. Technologies|June 16, 2019
Targeted protein degradation mechanismsYi Zhang, Christine Loh, Jesse Chen, et al.
Journal of Environmental Management|June 12, 2018
The roles of scientific research and stakeholder engagement for evidence-based policy formulation on shipping emissions control in Hong KongYiqi Zhang, Christine Loh, Peter K K Louie, et al.
Frontiers in Medicine|July 11, 2022
Genome-Wide Association Study and Gene-Based Analysis of Participants With Hemophilia A and Inhibitors in the My Life, Our Future Research RepositorySamuel Lessard, Chunla He, Deepak K Rajpal, et al.
Journal of Medicinal Chemistry|November 18, 2010
SIRT1 modulation as a novel approach to the treatment of diseases of agingCharles A Blum, James L Ellis, Christine Loh, et al.
Protein Expression and Purification|July 8, 2008
High yield expression of non-phosphorylated protein tyrosine kinases in insect cellsLeyu Wang, Meta Foster, Yan Zhang, et al.
Molecular Biosystems|October 9, 2010
Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technologyMatthew B Robers, Christine Loh, Coby B Carlson, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2009
Quinazolin-4-piperidin-4-methyl sulfamide PC-1 inhibitors: alleviating hERG interactions through structure based designSnahel D Patel, Wendy M Habeski, Alan C Cheng, et al.
Journal for Immunotherapy of Cancer|July 30, 2025
Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockadeDavid N Ciccone, Fu-Shan Kuo, Scott Boiko, et al.
Blood Advances|November 7, 2018
Recombinant factor VIII Fc fusion protein drives regulatory macrophage polarizationKatalin Kis-Toth, Gaurav Manohar Rajani, Allison Simpson, et al.
Journal of Toxicology and Environmental Health. Part A|June 24, 2008
Air pollution: costs and paths to a solution in Hong Kong--understanding the connections among visibility, air pollution, and health costs in pursuit of accountability, environmental justice, and health protectionAnthony J Hedley, Sarah M McGhee, Bill Barron, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Drug Discovery Today. Technologies|June 16, 2019
Targeted protein degradation mechanismsYi Zhang, Christine Loh, Jesse Chen, et al.
Journal of Environmental Management|June 12, 2018
The roles of scientific research and stakeholder engagement for evidence-based policy formulation on shipping emissions control in Hong KongYiqi Zhang, Christine Loh, Peter K K Louie, et al.
Frontiers in Medicine|July 11, 2022
Genome-Wide Association Study and Gene-Based Analysis of Participants With Hemophilia A and Inhibitors in the My Life, Our Future Research RepositorySamuel Lessard, Chunla He, Deepak K Rajpal, et al.
Journal of Medicinal Chemistry|November 18, 2010
SIRT1 modulation as a novel approach to the treatment of diseases of agingCharles A Blum, James L Ellis, Christine Loh, et al.
Protein Expression and Purification|July 8, 2008
High yield expression of non-phosphorylated protein tyrosine kinases in insect cellsLeyu Wang, Meta Foster, Yan Zhang, et al.
Molecular Biosystems|October 9, 2010
Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technologyMatthew B Robers, Christine Loh, Coby B Carlson, et al.
Bioorganic & Medicinal Chemistry Letters|May 14, 2009
Quinazolin-4-piperidin-4-methyl sulfamide PC-1 inhibitors: alleviating hERG interactions through structure based designSnahel D Patel, Wendy M Habeski, Alan C Cheng, et al.
Journal for Immunotherapy of Cancer|July 30, 2025
Highly selective HPK1 inhibitor NDI-101150 mediates immune cell activation and robust antitumor responses, distinct from immune checkpoint blockadeDavid N Ciccone, Fu-Shan Kuo, Scott Boiko, et al.
Blood Advances|November 7, 2018
Recombinant factor VIII Fc fusion protein drives regulatory macrophage polarizationKatalin Kis-Toth, Gaurav Manohar Rajani, Allison Simpson, et al.
Journal of Toxicology and Environmental Health. Part A|June 24, 2008
Air pollution: costs and paths to a solution in Hong Kong--understanding the connections among visibility, air pollution, and health costs in pursuit of accountability, environmental justice, and health protectionAnthony J Hedley, Sarah M McGhee, Bill Barron, et al.
Pageof 3